Pharmacotherapy of Chronic Neuropsychiatric Conditions During Pregnancy

Sarah M. Westberg; Regina Arellano; Nicole E. Cieri-Hutcherson; Natalie T. Heinrich; Alexandra M. Herman; Nicole M. Lodise; Sarah McBane; Theresa U. Ofili; Niamh O'Grady; Kjersten H. Sankey

doi:10.1016/j.nwh.2023.12.003

Pharmacotherapy of Chronic Neuropsychiatric Conditions During Pregnancy

Sarah M. Westberg
, Regina Arellano
, Nicole E. Cieri-Hutcherson
, Natalie T. Heinrich
, Alexandra M. Herman
, Nicole M. Lodise
, Sarah McBane
, Theresa U. Ofili
, Niamh O'Grady
, Kjersten H. Sankey

Pharmacy

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

Many pregnant persons will experience neuropsychiatric conditions during pregnancy, including migraine, attention deficit disorder, depression, and anxiety. Treatment of each of these conditions requires shared decision-making among the individual, family, and health care team. Although medications may include risk, the benefits often outweigh the potential fetal risks. In this article, we review pharmacologic treatment options for each of these conditions and appropriate use in pregnancy to maintain the stability of conditions and to optimize maternal and fetal outcomes.

Original language	English
Pages (from-to)	227-241
Number of pages	15
Journal	Nursing for Women's Health
Volume	28
Issue number	3
DOIs	https://doi.org/10.1016/j.nwh.2023.12.003
State	Published - Jun 2024

Keywords

ADHD
anxiety
attention deficit disorder
depression
major depressive disorder
medication
migraine
neuropsychiatric
pharmacotherapy
pregnancy

Access to Document

10.1016/j.nwh.2023.12.003

Cite this

@article{308e3d83c742400ea30d4946e75a9cdd,

title = "Pharmacotherapy of Chronic Neuropsychiatric Conditions During Pregnancy",

abstract = "Many pregnant persons will experience neuropsychiatric conditions during pregnancy, including migraine, attention deficit disorder, depression, and anxiety. Treatment of each of these conditions requires shared decision-making among the individual, family, and health care team. Although medications may include risk, the benefits often outweigh the potential fetal risks. In this article, we review pharmacologic treatment options for each of these conditions and appropriate use in pregnancy to maintain the stability of conditions and to optimize maternal and fetal outcomes.",

keywords = "ADHD, anxiety, attention deficit disorder, depression, major depressive disorder, medication, migraine, neuropsychiatric, pharmacotherapy, pregnancy",

author = "Westberg, \{Sarah M.\} and Regina Arellano and Cieri-Hutcherson, \{Nicole E.\} and Heinrich, \{Natalie T.\} and Herman, \{Alexandra M.\} and Lodise, \{Nicole M.\} and Sarah McBane and Ofili, \{Theresa U.\} and Niamh O'Grady and Sankey, \{Kjersten H.\}",

note = "Publisher Copyright: {\textcopyright} 2024 AWHONN",

year = "2024",

month = jun,

doi = "10.1016/j.nwh.2023.12.003",

language = "English",

volume = "28",

pages = "227--241",

journal = "Nursing for Women's Health",

issn = "1751-4851",

publisher = "Elsevier B.V.",

number = "3",

}

TY - JOUR

T1 - Pharmacotherapy of Chronic Neuropsychiatric Conditions During Pregnancy

AU - Westberg, Sarah M.

AU - Arellano, Regina

AU - Cieri-Hutcherson, Nicole E.

AU - Heinrich, Natalie T.

AU - Herman, Alexandra M.

AU - Lodise, Nicole M.

AU - McBane, Sarah

AU - Ofili, Theresa U.

AU - O'Grady, Niamh

AU - Sankey, Kjersten H.

PY - 2024/6

Y1 - 2024/6

N2 - Many pregnant persons will experience neuropsychiatric conditions during pregnancy, including migraine, attention deficit disorder, depression, and anxiety. Treatment of each of these conditions requires shared decision-making among the individual, family, and health care team. Although medications may include risk, the benefits often outweigh the potential fetal risks. In this article, we review pharmacologic treatment options for each of these conditions and appropriate use in pregnancy to maintain the stability of conditions and to optimize maternal and fetal outcomes.

AB - Many pregnant persons will experience neuropsychiatric conditions during pregnancy, including migraine, attention deficit disorder, depression, and anxiety. Treatment of each of these conditions requires shared decision-making among the individual, family, and health care team. Although medications may include risk, the benefits often outweigh the potential fetal risks. In this article, we review pharmacologic treatment options for each of these conditions and appropriate use in pregnancy to maintain the stability of conditions and to optimize maternal and fetal outcomes.

KW - ADHD

KW - anxiety

KW - attention deficit disorder

KW - depression

KW - major depressive disorder

KW - medication

KW - migraine

KW - neuropsychiatric

KW - pharmacotherapy

KW - pregnancy

UR - https://www.scopus.com/pages/publications/85193032169

U2 - 10.1016/j.nwh.2023.12.003

DO - 10.1016/j.nwh.2023.12.003

M3 - Article

C2 - 38702041

AN - SCOPUS:85193032169

SN - 1751-4851

VL - 28

SP - 227

EP - 241

JO - Nursing for Women's Health

JF - Nursing for Women's Health

IS - 3

ER -

Pharmacotherapy of Chronic Neuropsychiatric Conditions During Pregnancy

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this